Stockreport

Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift [Seeking Alpha]

Lifecore Biomedical, Inc.  (LFCR) 
PDF Paul Josephs, President, CEO & Director, stated that "2025 was a highly productive year for Lifecore Biomedical, during which we strengthened our pipeline, capabilities [Read more]